At a glance
ClinicalIndex Comparison RecordN/ACompleted· 42 enrolled
Drug / intervention
MucoPEG +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of MucoPEG™ for Xerostomia
In Brief
A clinical study evaluating MucoPEG and Biotene for Dry Mouth and Xerostomia. Completed, enrolled 42 participants across 2 sites.
Detailed Summary
The purpose of this study is to evaluate the effectiveness of the oral rinse comparing to MucoPEG™ and Biotene®. This is a randomized open-label crossover study with 42 patients receiving treatment. Patients will be randomly assigned to receive either the MucoPEG™ or the Biotene® Dry Mouth Gentle Oral Rinse in the first period. Patients will use the assigned oral rinse two times a day for two weeks. Patients will switch to the other treatment after a wash-out period of one week.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Mouth, Xerostomia
CountriesUnited States
Timeline
N/ACompletedFinished
20222023202420252026
First PostedAug 2021
Enrollment StartMay 2022
Primary CompletionSep 2022
Study CompletionNov 2022
TodayJul 2026
First PostedAug 2, 2021
Enrollment StartMay 2, 2022
Primary CompletionSep 15, 2022
Study CompletionNov 15, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.9 years ago
Interventions
MucoPEGdevice
Experimental
Biotenedevice
Active Comparator